Literature DB >> 1915269

The GTPase stimulatory activities of the neurofibromatosis type 1 and the yeast IRA2 proteins are inhibited by arachidonic acid.

M Golubić1, K Tanaka, S Dobrowolski, D Wood, M H Tsai, M Marshall, F Tamanoi, D W Stacey.   

Abstract

Three proteins, GTPase activating protein (GAP), neurofibromatosis 1 (NF1) and the yeast inhibitory regulator of the RAS-cAMP pathway (IRA2), have the ability to stimulate the GTPase activity of Ras proteins from higher animals or yeast. Previous studies indicate that certain lipids are able to inhibit this activity associated with the mammalian GAP protein. Inhibition of GAP would be expected to biologically activate Ras protein. In these studies arachidonic acid is shown also to inhibit the activity of the catalytic fragments of the other two proteins, mammalian NF1 and the yeast IRA2 proteins. In addition, phosphatidic acid (containing arachidonic and stearic acid) was inhibitory for the catalytic fragment of NF1 protein, but did not inhibit the catalytic fragments of GAP or IRA2 proteins. These observations emphasize the biochemical similarity of these proteins and provide support for the suggestion that lipids might play an important role in their biological control, and therefore also in the control of Ras activity and cellular proliferation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915269      PMCID: PMC453002          DOI: 10.1002/j.1460-2075.1991.tb07839.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  30 in total

1.  Preferential inhibition of the oncogenic form of RasH by mutations in the GAP binding/"effector" domain.

Authors:  C L Farnsworth; M S Marshall; J B Gibbs; D W Stacey; L A Feig
Journal:  Cell       Date:  1991-02-08       Impact factor: 41.582

2.  Serum stimulation of NIH 3T3 cells induces the production of lipids able to inhibit GTPase-activating protein activity.

Authors:  C L Yu; M H Tsai; D W Stacey
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

3.  The effect of GTPase activating protein upon ras is inhibited by mitogenically responsive lipids.

Authors:  M H Tsai; C L Yu; F S Wei; D W Stacey
Journal:  Science       Date:  1989-01-27       Impact factor: 47.728

4.  The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.

Authors:  R Ballester; D Marchuk; M Boguski; A Saulino; R Letcher; M Wigler; F Collins
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

5.  The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae.

Authors:  G F Xu; B Lin; K Tanaka; D Dunn; D Wood; R Gesteland; R White; R Weiss; F Tamanoi
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

6.  The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21.

Authors:  G A Martin; D Viskochil; G Bollag; P C McCabe; W J Crosier; H Haubruck; L Conroy; R Clark; P O'Connell; R M Cawthon
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

7.  Ras GTPase-activating protein physically associates with mitogenically active phospholipids.

Authors:  M H Tsai; M Roudebush; S Dobrowolski; C L Yu; J B Gibbs; D W Stacey
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

8.  IRA2, an upstream negative regulator of RAS in yeast, is a RAS GTPase-activating protein.

Authors:  K Tanaka; B K Lin; D R Wood; F Tamanoi
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

9.  The inhibition of the GTPase activating protein-Ha-ras interaction by acidic lipids is due to physical association of the C-terminal domain of the GTPase activating protein with micellar structures.

Authors:  J Serth; A Lautwein; M Frech; A Wittinghofer; A Pingoud
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

10.  A C-terminal domain of GAP is sufficient to stimulate ras p21 GTPase activity.

Authors:  M S Marshall; W S Hill; A S Ng; U S Vogel; M D Schaber; E M Scolnick; R A Dixon; I S Sigal; J B Gibbs
Journal:  EMBO J       Date:  1989-04       Impact factor: 11.598

View more
  4 in total

1.  Functional interactions of phosphatidylinositol 3-kinase with GTPase-activating protein in 3T3-L1 adipocytes.

Authors:  D DePaolo; J E Reusch; K Carel; P Bhuripanyo; J W Leitner; B Draznin
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

Review 2.  Molecular genetics of neurofibromatosis type 1 (NF1).

Authors:  M H Shen; P S Harper; M Upadhyaya
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

3.  Structural analysis of the GAP-related domain from neurofibromin and its implications.

Authors:  K Scheffzek; M R Ahmadian; L Wiesmüller; W Kabsch; P Stege; F Schmitz; A Wittinghofer
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

4.  A porcine model of neurofibromatosis type 1 that mimics the human disease.

Authors:  Katherine A White; Vicki J Swier; Jacob T Cain; Jordan L Kohlmeyer; David K Meyerholz; Munir R Tanas; Johanna Uthoff; Emily Hammond; Hua Li; Frank A Rohret; Adam Goeken; Chun-Hung Chan; Mariah R Leidinger; Shaikamjad Umesalma; Margaret R Wallace; Rebecca D Dodd; Karin Panzer; Amy H Tang; Benjamin W Darbro; Aubin Moutal; Song Cai; Wennan Li; Shreya S Bellampalli; Rajesh Khanna; Christopher S Rogers; Jessica C Sieren; Dawn E Quelle; Jill M Weimer
Journal:  JCI Insight       Date:  2018-06-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.